Home/Publication/Sherpa, Lilly Asia Join US Healthcare Titans in Cancer Treatments
Sherpa, Lilly Asia Join US Healthcare Titans in Cancer Treatments 

15 May 2025

US$ 20.00

China’s Sherpa Healthcare Partners (Sherpa) and MRL Ventures Fund (MRLV) made their follow-on investments in the US$39 m...

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 16 May 2025...

Listen to Australia/New Zealand People on the Move (Subscribers' Weekly 16 May 2025)...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.